MOBILEYE GLOBAL INC-A (MBLY) Fundamental Analysis & Valuation

NASDAQ:MBLY • US60741F1049

Current stock price

9.01 USD
-0.22 (-2.38%)
At close:
9.0498 USD
+0.04 (+0.44%)
After Hours:

This MBLY fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. MBLY Profitability Analysis

1.1 Basic Checks

  • In the past year MBLY was profitable.
  • MBLY had a positive operating cash flow in the past year.
  • In the past 5 years MBLY always reported negative net income.
  • Each year in the past 5 years MBLY had a positive operating cash flow.
MBLY Yearly Net Income VS EBIT VS OCF VS FCFMBLY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 -1B -2B -3B

1.2 Ratios

  • MBLY has a worse Return On Assets (-47.03%) than 85.71% of its industry peers.
  • MBLY has a worse Return On Equity (-50.32%) than 69.05% of its industry peers.
Industry RankSector Rank
ROA -47.03%
ROE -50.32%
ROIC N/A
ROA(3y)-9.29%
ROA(5y)-5.77%
ROE(3y)-9.68%
ROE(5y)-6.01%
ROIC(3y)N/A
ROIC(5y)N/A
MBLY Yearly ROA, ROE, ROICMBLY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 -5 -10 -15 -20 -25

1.3 Margins

  • The Gross Margin of MBLY (48.26%) is better than 97.62% of its industry peers.
  • In the last couple of years the Gross Margin of MBLY has grown nicely.
  • MBLY does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 48.26%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.09%
GM growth 5Y4.19%
MBLY Yearly Profit, Operating, Gross MarginsMBLY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. MBLY Health Analysis

2.1 Basic Checks

  • MBLY does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for MBLY has been increased compared to 1 year ago.
  • The number of shares outstanding for MBLY has been increased compared to 5 years ago.
  • There is no outstanding debt for MBLY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
MBLY Yearly Shares OutstandingMBLY Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M
MBLY Yearly Total Debt VS Total AssetsMBLY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.2 Solvency

  • MBLY has an Altman-Z score of 7.28. This indicates that MBLY is financially healthy and has little risk of bankruptcy at the moment.
  • MBLY has a Altman-Z score of 7.28. This is amongst the best in the industry. MBLY outperforms 90.48% of its industry peers.
  • There is no outstanding debt for MBLY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 7.28
ROIC/WACCN/A
WACC8.53%
MBLY Yearly LT Debt VS Equity VS FCFMBLY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.3 Liquidity

  • A Current Ratio of 4.76 indicates that MBLY has no problem at all paying its short term obligations.
  • MBLY has a Current ratio of 4.76. This is amongst the best in the industry. MBLY outperforms 92.86% of its industry peers.
  • A Quick Ratio of 4.03 indicates that MBLY has no problem at all paying its short term obligations.
  • MBLY's Quick ratio of 4.03 is amongst the best of the industry. MBLY outperforms 90.48% of its industry peers.
Industry RankSector Rank
Current Ratio 4.76
Quick Ratio 4.03
MBLY Yearly Current Assets VS Current LiabilitesMBLY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. MBLY Growth Analysis

3.1 Past

  • The earnings per share for MBLY have decreased by 0.00% in the last year.
  • The Revenue has grown by 8.69% in the past year. This is quite good.
  • The Revenue has been growing by 14.39% on average over the past years. This is quite good.
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
Revenue 1Y (TTM)8.69%
Revenue growth 3Y0.44%
Revenue growth 5Y14.39%
Sales Q2Q%27.4%

3.2 Future

  • MBLY is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 30.09% yearly.
  • MBLY is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 24.89% yearly.
EPS Next Y-26.53%
EPS Next 2Y3.23%
EPS Next 3Y22.26%
EPS Next 5Y30.09%
Revenue Next Year3.6%
Revenue Next 2Y8.65%
Revenue Next 3Y14.26%
Revenue Next 5Y24.89%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
MBLY Yearly Revenue VS EstimatesMBLY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B 4B 5B
MBLY Yearly EPS VS EstimatesMBLY Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.2 0.4 0.6 0.8 1

More info and screens

Find the best growth stocksShow best growing peers

2

4. MBLY Valuation Analysis

4.1 Price/Earnings Ratio

  • MBLY is valuated rather expensively with a Price/Earnings ratio of 22.52.
  • MBLY's Price/Earnings ratio is in line with the industry average.
  • MBLY's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.35.
  • The Price/Forward Earnings ratio is 23.49, which indicates a rather expensive current valuation of MBLY.
  • Based on the Price/Forward Earnings ratio, MBLY is valued a bit more expensive than the industry average as 66.67% of the companies are valued more cheaply.
  • When comparing the Price/Forward Earnings ratio of MBLY to the average of the S&P500 Index (22.23), we can say MBLY is valued inline with the index average.
Industry RankSector Rank
PE 22.53
Fwd PE 23.49
MBLY Price Earnings VS Forward Price EarningsMBLY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • MBLY's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. MBLY is more expensive than 64.29% of the companies in the same industry.
  • MBLY's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 16.03
EV/EBITDA 69.88
MBLY Per share dataMBLY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

  • A more expensive valuation may be justified as MBLY's earnings are expected to grow with 22.26% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y3.23%
EPS Next 3Y22.26%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. MBLY Dividend Analysis

5.1 Amount

  • MBLY does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MBLY Fundamentals: All Metrics, Ratios and Statistics

MOBILEYE GLOBAL INC-A

NASDAQ:MBLY (4/27/2026, 8:00:58 PM)

After market: 9.0498 +0.04 (+0.44%)

9.01

-0.22 (-2.38%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)04-23
Earnings (Next)07-22
Inst Owners63.33%
Inst Owner Change0.25%
Ins Owners11.39%
Ins Owner Change72.39%
Market Cap7.58B
Revenue(TTM)2.01B
Net Income(TTM)-4.11B
Analysts73.33
Price Target14.13 (56.83%)
Short Float %17.56%
Short Ratio4.78
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)18.19%
Min EPS beat(2)-2.19%
Max EPS beat(2)38.57%
EPS beat(4)3
Avg EPS beat(4)15.59%
Min EPS beat(4)-2.19%
Max EPS beat(4)38.57%
EPS beat(8)7
Avg EPS beat(8)12.57%
EPS beat(12)10
Avg EPS beat(12)12.88%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)3.69%
Min Revenue beat(2)1.14%
Max Revenue beat(2)6.24%
Revenue beat(4)4
Avg Revenue beat(4)3.31%
Min Revenue beat(4)1.14%
Max Revenue beat(4)6.24%
Revenue beat(8)7
Avg Revenue beat(8)1.92%
Revenue beat(12)8
Avg Revenue beat(12)0.95%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.73%
PT rev (3m)-21.08%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-38.49%
EPS NY rev (1m)-1.45%
EPS NY rev (3m)-33.67%
Revenue NQ rev (1m)-0.04%
Revenue NQ rev (3m)-3.57%
Revenue NY rev (1m)0.05%
Revenue NY rev (3m)-1.24%
Valuation
Industry RankSector Rank
PE 22.53
Fwd PE 23.49
P/S 3.76
P/FCF 16.03
P/OCF 13.35
P/B 0.93
P/tB 3.66
EV/EBITDA 69.88
EPS(TTM)0.4
EY4.44%
EPS(NY)0.38
Fwd EY4.26%
FCF(TTM)0.56
FCFY6.24%
OCF(TTM)0.68
OCFY7.49%
SpS2.39
BVpS9.7
TBVpS2.46
PEG (NY)N/A
PEG (5Y)N/A
Graham Number9.34494 (3.72%)
Profitability
Industry RankSector Rank
ROA -47.03%
ROE -50.32%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 48.26%
FCFM 23.49%
ROA(3y)-9.29%
ROA(5y)-5.77%
ROE(3y)-9.68%
ROE(5y)-6.01%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.09%
GM growth 5Y4.19%
F-Score5
Asset Turnover0.23
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 18.23%
Cap/Sales 4.72%
Interest Coverage N/A
Cash Conversion 631.11%
Profit Quality N/A
Current Ratio 4.76
Quick Ratio 4.03
Altman-Z 7.28
F-Score5
WACC8.53%
ROIC/WACCN/A
Cap/Depr(3y)16.8%
Cap/Depr(5y)19.43%
Cap/Sales(3y)4.59%
Cap/Sales(5y)6.01%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
EPS Next Y-26.53%
EPS Next 2Y3.23%
EPS Next 3Y22.26%
EPS Next 5Y30.09%
Revenue 1Y (TTM)8.69%
Revenue growth 3Y0.44%
Revenue growth 5Y14.39%
Sales Q2Q%27.4%
Revenue Next Year3.6%
Revenue Next 2Y8.65%
Revenue Next 3Y14.26%
Revenue Next 5Y24.89%
EBIT growth 1Y-5.38%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year25.65%
EBIT Next 3Y42.45%
EBIT Next 5Y38.51%
FCF growth 1Y179.88%
FCF growth 3Y6.33%
FCF growth 5Y23.78%
OCF growth 1Y115.97%
OCF growth 3Y3.31%
OCF growth 5Y17.31%

MOBILEYE GLOBAL INC-A / MBLY Fundamental Analysis FAQ

What is the fundamental rating for MBLY stock?

ChartMill assigns a fundamental rating of 5 / 10 to MBLY.


Can you provide the valuation status for MOBILEYE GLOBAL INC-A?

ChartMill assigns a valuation rating of 2 / 10 to MOBILEYE GLOBAL INC-A (MBLY). This can be considered as Overvalued.


What is the profitability of MBLY stock?

MOBILEYE GLOBAL INC-A (MBLY) has a profitability rating of 3 / 10.


What are the PE and PB ratios of MOBILEYE GLOBAL INC-A (MBLY) stock?

The Price/Earnings (PE) ratio for MOBILEYE GLOBAL INC-A (MBLY) is 22.53 and the Price/Book (PB) ratio is 0.93.


What is the expected EPS growth for MOBILEYE GLOBAL INC-A (MBLY) stock?

The Earnings per Share (EPS) of MOBILEYE GLOBAL INC-A (MBLY) is expected to decline by -26.53% in the next year.